Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma

被引:96
作者
Choedon, Tenzin
Mathan, Ganeshan
Arya, Soneera
Kumar, Vijay L.
Kumar, Vijay
机构
[1] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India
[2] All India Inst Med Sci, Dept Pharmacol, New Delhi 110029, India
关键词
Calotropis procera; transgenic mice; hepatocellular carcinoma; cytotoxicity; anticancer agent; differential killing;
D O I
10.3748/wjg.v12.i16.2517
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the anticancer property of the dried latex (DL) of Calotropis procera, a tropical medicinal plant, in the X15-myc transgenic mouse model of hepatocellular carcinoma and to elucidate its mechanism of action in cell culture. METHODS: The young transgenic mice were orally fed with the aqueous suspension of DL (400 mg/kg for 5 d/wk) for 15 wk and their liver was examined for histopathological changes at 20 wk. Serum levels of vascular endothelial growth factor (VEGF) were also measured in these animals. To characterize the active fraction, DL was extracted with petroleum ether followed by methanol. The methanolic extract was sub-fractionated on a silica gel G column using a combination of non-polar and polar solvents and eleven fractions were obtained. Each fraction was analysed for cytotoxic effect on hepatoma (Huh7) and non-hepatoma (COS-1) cell lines and non-transformed hepatocytes (AML12) using tetrazolium (MTT) assay. Finally, the mechanism of cell death was investigated by measuring the levels of Bcl2, caspase 3 and DNA fragmentation. RESULTS: DL treatment of mice showed a complete protection against hepatocarcinogenesis. No adverse effect was observed in these animals. The serum VEGF level was significantly lowered in the treated mice as compared to control animals. Cell culture studies revealed that the methanolic extract of DL as well as its fraction 8 induced extensive cell death in both Huh-7 and COS-1 cells while AML12 cells were spared. This was accompanied by extensive fragmentation of DNA in Huh-7 and COS-1 cells. No change in the levels of canonical markers of apoptosis such as Bcl2 and caspase 3 was observed. CONCLUSION: DL of C. procera has the potential for anti-cancer therapy due to its differentiable targets and non-interference with regular pathway of apoptosis. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:2517 / 2522
页数:6
相关论文
共 33 条
[1]
Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation [J].
Arya, S ;
Kumar, VL .
MEDIATORS OF INFLAMMATION, 2005, (04) :228-232
[2]
PRELIMINARY STUDIES ON THE ANTIINFLAMMATORY AND ANALGESIC ACTIVITIES OF CALOTROPIS-PROCERA ROOT EXTRACT [J].
BASU, A ;
CHAUDHURI, AKN .
JOURNAL OF ETHNOPHARMACOLOGY, 1991, 31 (03) :319-324
[3]
BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053
[4]
Chay Christopher H, 2002, Clin Prostate Cancer, V1, P14, DOI 10.3816/CGC.2002.n.002
[5]
Cheng ASL, 2004, INT J ONCOL, V24, P853
[6]
Selective killing of preneoplastic and neoplastic cells by methotrexate with leucovorin [J].
Chow, M ;
Rubin, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4550-4555
[7]
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer:: antitumor activity and correlation with vascular endothelial growth factor levels [J].
Colleoni, M ;
Rocca, A ;
Sandri, MT ;
Zorzino, L ;
Masci, G ;
Nolè, F ;
Peruzzotti, G ;
Robertson, C ;
Orlando, L ;
Cinieri, S ;
de Braud, F ;
Viale, G ;
Goldhirsch, A .
ANNALS OF ONCOLOGY, 2002, 13 (01) :73-80
[8]
Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219
[9]
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma [J].
Deplanque, G ;
Madhusudan, S ;
Jones, PH ;
Wellmann, S ;
Christodoulos, K ;
Talbot, DC ;
Ganesan, TS ;
Blann, A ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 2004, 91 (09) :1645-1650
[10]
Surgical management of lung cancer [J].
Downey, RJ .
JOURNAL OF THORACIC IMAGING, 1999, 14 (04) :266-269